drug rebates

Testing requirements are likely slowing biosimilar entries in the US
Testing requirements are likely slowing biosimilar entries in the US
RAPS.org
biosimilars
regulatory
patents
drug rebates
Flag link:
Pharmacy benefit managers forwarded more than 99% of Part D rebates, GAO says
Pharmacy benefit managers forwarded more than 99% of Part D rebates, GAO says
Beckers Hospital Review
PBMs
drug rebates
Medicare Part D
Flag link:
Six Reasons Why the Rebate Rule Failed—And What’s Next
Six Reasons Why the Rebate Rule Failed—And What’s Next
Drug Channels
HHS
drug rebates
Flag link:
White House pulls drug rebate rule to relief of payers
White House pulls drug rebate rule to relief of payers
Biopharma Dive
payers
drug rebates
Medicaid
Medicare
PBMs
Flag link:
The Road to 2020: Understanding the Regulatory Timeline for Part D Rebate Reform
The Road to 2020: Understanding the Regulatory Timeline for Part D Rebate Reform
Drug Channels
Medicare
Medicare Part D
drug rebates
HHA
Flag link:
CMS demo could pave the path to eliminating Part D rebates
CMS demo could pave the path to eliminating Part D rebates
BioCentury
CMS
drug pricing
Medicare Part D
drug rebates
Flag link:
Employers Are Absorbing Even More Manufacturer Rebates from Their PBMs
Employers Are Absorbing Even More Manufacturer Rebates from Their PBMs
Drug Channels
employers
PBMs
drug rebates
Flag link:
3 Big Pharmas Trying to Pop the Rebate Bubble
3 Big Pharmas Trying to Pop the Rebate Bubble
Motley Fool
drug pricing
drug rebates
Eli Lilly
Amgen
Gilead Sciences
Flag link:
A Closer Look At The Drug Rebate Proposal
A Closer Look At The Drug Rebate Proposal
Forbes
drug pricing
drug rebates
Donald Trump
healthcare reform
Amgen
Flag link:
Sanofi handed payers nearly $12B in drug rebates last year
Sanofi handed payers nearly $12B in drug rebates last year
Biopharma Dive
Sanofi
rebates
drug rebates
insurers
PBMs
Flag link:
Novartis CEO lauds Trump administration plan to overhaul rebates
Novartis CEO lauds Trump administration plan to overhaul rebates
Yahoo/Reuters
Novartis
Vas Narasimhan
Pharma CEOs
drug pricing
Donald Trump
drug rebates
Flag link:
Azar calls on Congress to help eliminate drug rebates
Azar calls on Congress to help eliminate drug rebates
Stat
drug pricing
drug rebates
Alex Azar
HHS
US Congress
Flag link:
J&J chief figures Amazon could shake up pharma's distribution, rebates and more
J&J chief figures Amazon could shake up pharma's distribution, rebates and more
Fierce Pharma
Amazon
JNJ
Pharma CEOs
Alex Gorsky
distribution
drug rebates
Flag link:
New York flags 42 drugs for supplemental Medicaid rebates
New York flags 42 drugs for supplemental Medicaid rebates
BioCentury
New York
Medicaid
drug rebates
Flag link:
Did HHS chief Alex Azar work with ex-employer Lilly on drug rebate plans? A watchdog wants to know
Did HHS chief Alex Azar work with ex-employer Lilly on drug rebate plans? A watchdog wants to know
Fierce Pharma
drug rebates
Alex Azar
HHS
Eli Lilly
Flag link:
HHS Secretary Azar Says Drug Rebate Program Can Be Eliminated by His Agency: Report
HHS Secretary Azar Says Drug Rebate Program Can Be Eliminated by His Agency: Report
BioSpace
HHS
Alex Azar
drug rebates
Flag link:
CVS, Express Scripts provide a rare moment of transparency on rebate profits
CVS, Express Scripts provide a rare moment of transparency on rebate profits
Fierce Healthcare
drug rebates
CVS Health
Express Scripts
PBMs
Flag link:
A System Without Rebates: The Drug Channels Negotiated Discounts Model
A System Without Rebates: The Drug Channels Negotiated Discounts Model
Drug Channels
rebates
drug rebates
Flag link:
Here's Why Big Pharma Loves This Plan to Lower Drug Prices
Here's Why Big Pharma Loves This Plan to Lower Drug Prices
Motley Fool
drug pricing
HHS
drug rebates
Flag link:
Azar says 'change is coming' for 340B
Azar says 'change is coming' for 340B
Biopharma Dive
340B
HHS
Alex Azar
drug rebates
Flag link:

Pages